Iain A. McNeish
Imperial College London(GB)
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, PARP inhibition in cancer therapy, Virus-based gene therapy research, CRISPR and Genetic Engineering, Cancer Genomics and Diagnostics
Most-Cited Works
- → Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial(2017)1,678 cited
- → Rethinking ovarian cancer: recommendations for improving outcomes(2011)1,500 cited
- → Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer(2015)1,397 cited
- → Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial(2016)1,190 cited
- → ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease(2019)1,130 cited
- → Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk(2015)906 cited
- → Paraneoplastic Thrombocytosis in Ovarian Cancer(2012)814 cited
- → “Re-educating” tumor-associated macrophages by targeting NF-κB(2008)774 cited
- → A Phase I Study of OncoVEXGM-CSF, a Second-Generation Oncolytic Herpes Simplex Virus Expressing Granulocyte Macrophage Colony-Stimulating Factor(2006)565 cited
- → Copy number signatures and mutational processes in ovarian carcinoma(2018)445 cited